Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( 🔒 ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Need Help

PHASER ? Pluridirectional High-energy Agile Scanning Electronic Radiotherapy

Award Number: R43CA217607
ORGANIZATION: NATIONAL CANCER INSTITUTE
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 03/17/2017
PERIOD OF PERFORMANCE END DATE: 12/16/2019

Group Awards By:

View Award Description

PHASER ? Pluridirectional High-energy Agile Scanning Electronic Radiotherapy - PROJECT SUMMARY/ABSTRACT The mission of TibaRay, Inc. is to develop and clinically translate next-generation radiation therapy technologies for the treatment of cancer, the single leading cause of death worldwide and increasing epidemically. A major advance in radiation therapy (RT) that has increased its curative potential and decreased side effects is the ability to sculpt radiation doses exquisitely in 3D to conform to tumors and spare surrounding normal organs. This dose sculpting is achieved by delivering radiation beams to the tumor from multiple directions, each of which has an optimized spatial intensity distribution. However, the fastest treatment times are still minutes long, limited by both beam intensities in electron linacs and the mechanical systems that are used to direct and shape the treatment beams. To address these major shortcomings of current state-of-the-art radiation delivery systems, TibaRay is proposing a radical new design for RT systems, Pluridirectional High-energy Agile Scanning Electronic Radiotherapy (PHASER), based on patented, novel technologies to produce intensity-modulated therapeutic energy x-ray beams from multiple directions using no mechanical systems to direct or shape the treatment beams. This is achieved by using an array of novel electron linacs each of which uses a magnetic electron beam scanning scheme paired with an extended bremsstrahlung target and multi-channel collimator array system referred to as Scanning Pencil-array-collimated High Speed Intensity-modulated X-ray source (SPHINX). The multiple linacs obviate the need to move a single linac on a gantry to achieve different beam directions and SPHINX eliminates the need for mechanical moving parts, e.g., multi-leaf collimators (MLCs), for therapy beam shaping. Each of the novel linacs used in PHASER are far more efficient and will generate more beam than conventional medical linacs. In the full PHASER design, it is estimated that the treatment time can be reduced to less than one second, effectively freezing physiological motion. The novel accelerator technology uses much simpler manufacturing techniques and production costs for PHASER are projected to be about the same as current state-of-the-art systems and maintenance/downtime costs should be lower. Initial proof of principle for the subsystems needed for PHASER have been demonstrated. TibaRay, in partnership with the Stanford University Department of Radiation Oncology and the SLAC National Acceleratory Laboratory, proposes to design (Phase I), build and test, and optimize a two-beam PHASER prototype (Phase II). In Phase III, TibaRay will develop the full PHASER prototype which will lead directly to commercialization and clinical translation. Our novel technology will help fill a tremendous worldwide need for high-quality, cost-effective radiation therapy for cancer.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2020 ( Subtotal = $0 )
2020	2017	TIBARAY, INC.	1306 REAMWOOD AVE	SUNNYVALE	CA	94089	SANTA CLARA	USA	Cancer Cause and Prevention Research	000	1	4/11/2020	NEW	$0
														Subtotal = $0

Issue Date FY: 2019 ( Subtotal = $0 )
2019	2017	TIBARAY, INC.	854 LATHROP DR	STANFORD	CA	94305	SANTA CLARA	USA	Cancer Cause and Prevention Research	000	1	1/2/2019	NEW	$0
														Subtotal = $0

Issue Date FY: 2017 ( Subtotal = $224,658 )
2017	2017	TIBARAY, INC.	854 LATHROP DR	STANFORD	CA	94305	SANTA CLARA	USA	Cancer Cause and Prevention Research	000	1	3/17/2017	NEW	$224,658
														Subtotal = $224,658

Grand Total All Awards = $224,658

Top

All Categories

About

Search

Reports

Data Submission

Award Information

PHASER ? Pluridirectional High-energy Agile Scanning Electronic Radiotherapy

Award Number: R43CA217607

ORGANIZATION: NATIONAL CANCER INSTITUTE

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 03/17/2017

PERIOD OF PERFORMANCE END DATE: 12/16/2019

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer